论文部分内容阅读
为观察中药密骨胶囊对骨质疏松症的作用 ,将原发性骨质疏松症患者 10 0例随机分成治疗组 6 0例、对照组 40例。治疗组口服中药密骨胶囊 (每日 2次 ,每次 2粒 ) ,并肌肉注射丙酸睾丸酮 (每次 2 5mg ,每周 2次 ) ,3个月为一疗程 ;疗程结束后 ,停用丙酸睾丸酮 ,续服中药 ,2个月后再行第 2个疗程。对照组用补钙剂或镇痛剂对症治疗。 8个月后分别统计骨痛改善程度、骨密度值。结果 :疼痛改善优良率治疗组为 73 3% ,对照组为 30 .0 % ;骨密度值增加或不变率治疗组为 5 6 7% ,对照组为 10 .0 % ;治疗组均优于对照组 (P <0 0 1;P <0 0 5 )
To observe the effect of Migu capsule on osteoporosis, 100 patients with primary osteoporosis were randomly divided into treatment group (60 cases) and control group (40 cases). The treatment group was orally administered with Migu Capsule (twice a day, 2 capsules each time) and intramuscular injection of testosterone propionate (25mg twice a week) for 3 months for one course of treatment; after the course of treatment was discontinued Testosterone propionate, continued serving traditional Chinese medicine, 2 months after the first two courses. Control group with calcium or analgesic symptomatic treatment. After 8 months, respectively, the improvement of bone mineral density, bone mineral density value. Results: The improvement rate of pain was 73.3% in the treatment group and 30.0% in the control group. The BMD value was 56.7% in the untreated group and 10.0% in the control group. The treatment group was superior to the control group Control group (P <0 01; P <0 05)